Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Levy Richard S
Relationship:  
City:   Wilmington
State:   DE
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   67,748    

Indirect Shares

   0      
Direct Value   $3,761,816    

Indirect Value

   $0      
Total Shares   67,748      
Total Value   $3,761,816      


Incyte Corp $991,356 Madrigal Pharmaceuticals Inc $2,516,316 Protara Therapeutics, Inc $86,490 Kodiak Sciences Inc. $2,970 Kiniksa Pharmaceuticals, Ltd. $164,684 Incyte Corp $991,356 Madrigal Pharmaceuticals Inc $2,516,316 Protara Therapeutics, Inc $86,490 Kodiak Sciences Inc. $2,970 Kiniksa Pharmaceuticals, Ltd. $164,684
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   195.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY EVP, Chief Drug Dev Of... 2016-01-06 16,926 2010-03-15 0    Premium*  
            Madrigal Pharmaceuticals Inc MDGL 2024-04-01 10,298 2017-08-21 0    Premium*  
            Protara Therapeutics, Inc TARA Director 2020-01-10 31,000 2020-01-10 0    Premium*  
            Kodiak Sciences Inc. KOD Director 2020-03-20 1,000 2020-03-20 0    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA 2024-05-03 8,524 2023-06-29 0    Premium*  
* Premium Members only  

Records found :    81         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-09-11 4 AS $130.00 $559,130 D/D (4,301) 16,926 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-10-06 4 AS $122.29 $481,456 D/D (3,937) 16,926 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-11-06 4 AS $116.51 $458,583 D/D (3,936) 16,926 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-12-07 4 AS $106.18 $418,031 D/D (3,937) 16,926 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2016-01-06 4 AS $101.86 $401,023 D/D (3,937) 16,926 0 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-01-17 4 AS $285.28 $6,592,686 D/D (22,489) 9,100 0 %
MDGL Madrigal Pharmaceuticals ...   –       •      –    2024-04-01 4 AS $255.90 $2,832,335 D/D (11,000) 10,298 0 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2017-08-21 4 B $15.67 $56,358 D/D 3,550 3,550 2.39 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2017-08-22 4 B $15.99 $57,209 D/D 3,550 7,100 2.39 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2017-08-23 4 B $16.08 $32,236 D/D 2,000 9,100 2.39 -
KOD Kodiak Sciences Inc. Director   –       •      –    2020-03-20 4 B $43.37 $44,330 D/D 1,000 1,000 2.39 %
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2010-03-15 4 OE $4.19 $83,800 D/D 20,000 20,000 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2011-01-18 4 OE $4.19 $270,139 D/D 40,310 40,310 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2012-04-27 4 OE $8.19 $262,948 D/D 30,000 30,000 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2013-02-15 4 OE $5.46 $673,176 D/D 98,440 98,440 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2013-05-13 4 OE $7.09 $425,400 D/D 60,000 60,000 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2013-09-06 4 OE $11.98 $299,500 D/D 25,000 25,000 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-02-13 4 OE $3.11 $1,595,213 D/D 191,309 195,610 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-02-14 4 OE $9.41 $433,346 D/D 39,787 44,088 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-05-16 4 OE $14.72 $117,760 D/D 8,000 12,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-06-16 4 OE $14.72 $117,760 D/D 8,000 12,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-07-16 4 OE $14.72 $117,760 D/D 8,000 12,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-08-18 4 OE $14.72 $117,760 D/D 8,000 12,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-09-16 4 OE $14.72 $117,760 D/D 8,000 12,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-10-16 4 OE $14.72 $117,760 D/D 8,000 12,301 0 -
  81  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us